Now that Breast Cancer Awareness Month is over, you are probably wondering where exactly all the donations go and what you can do to help patients suffering from other forms of cancer. While breast cancer awareness campaigns have successfully reached out to women, many other, often more…

In the industry of pharmacy technology, the Food and Drug Administration have recently approved two new drug therapies for idiopathic pulmonary fibrosis. While the cause of the disease is unknown, research has found that the drugs Ofev (nintedanib) and Esbriet (pirfenidone) can significantly…

In a surprise discovery that topples decades of thinking on how the body fixes proteins, scientists have opened up new doors for protein-folding treatments, moving one step closer to preventing Alzheimer’s and other protein-linked brain diseases.1
“This finding provides a whole other outlook on…

Those in medical assisting programs may be interested in a recent gene therapy trial that potentially could benefit those with X-linked severe combined immunodeficiency, (usually shortened to SCID-X1), an inherited disorder of the immune system. The trial, published in the New England Journal…

The average American will live to 78 years and 9.5 months, setting a record high in the U.S., according to a new report released by the Centers for Disease Control and Prevention.1 Life expectancy for a child born in 2012 increased about six weeks from the life expectancy in 2010 and 2011,…

In the past several months, international health authorities have been racing to contain what is being called the “largest and most complex” outbreak of the deadly Ebola virus since its discovery.1 While students in medical assistant programs have certainly been paying attention to the virus,…

Those in physical therapy technology programs may be interested in a story about Darek Fidyka, the first man to receive a groundbreaking treatment that allowed him to walk again after experiencing a paralyzing stab wound. The procedure involved taking cells from Fidyka’s nasal cavity and…